(KOD)

NGM – Real Time Price. Currency in USD

37.00

-2.76 (-6.94%)

At close: Mar 27, 2026, 4:00 PM EDT

37.46

+0.46 (1.24%)

After-hours: Mar 27, 2026, 7:59 PM EDT

27.03.2026

KOD Stock Soars on Promising Phase III Data for Eye Disease Candidate

Kodiak Sciences rallies 75% as phase III GLOW2 data show Zenkuda's strong efficacy, safety and risk reduction in diabetic retinopathy patients.

27.03.2026

Kodiak Sciences Stock Is Surging Friday: What's Driving The Action?

Investors appear to be responding to both the strength of the data and the possibility of a faster path toward a biologics license application, or BLA. Here's what investors need to know.

26.03.2026

Kodiak Sciences shares surge after eye drug succeeds in late-stage study

Shares of drug developer Kodiak Sciences jumped 52% before the bell on Thursday after its experimental drug met the main goal in a ‌late-stage study in patients with diabetes-related eye damage.

26.03.2026

Kodiak Sciences Announces Positive Topline Results in GLOW2, the Second Phase 3 Study in Diabetic Retinopathy, Demonstrating Superiority of Zenkuda™ (tarcocimab tedromer) Over Sham

Building on the success of GLOW1 and with all patients on a 6-month dosing interval, Zenkuda (tarcocimab tedromer) demonstrated superiority to sham with 62.5% of Zenkuda-treated patients achieving a ≥2-step improvement in diabetic retinopathy severity score (DRSS) compared to 3.3% of sham-treated patients (p

09.03.2026

Investment Firm Doubles Down on Biotech Stock, Adds 386,000 Shares, According to Recent SEC Filing

Acquired 386,000 shares of Kodiak Sciences (NASDAQ: KOD); estimated transaction value of $7.90 million based on quarterly average pricing Quarter-end Kodiak Sciences position value rose by $19.49 million, reflecting both trading and price movement Transaction represented a 1.73% increase relative to fund 13F AUM Boxer Capital Management, LLC held 1,136,000 Kodiak Sciences shares valued at $31.76 million after the trade Kodiak Sciences position now represents 6.95% of 13F AUM, which places it outside the fund's top five holdings

23.02.2026

Kodiak Sciences Stock Up 480% as One Fund Discloses $53 Million Buy

Baker Bros. Advisors increased its Kodiak Sciences stake by 2,608,696 shares; the estimated trade size was $53.42 million.

19.02.2026

Inside a $58 Million Bet on Kodiak Amid $184 Million Offering and Phase 3 Readouts Ahead

Connecticut-based Braidwell bought 2,072,788 shares in Kodiak Sciences in the fourth quarter. The quarter-end position value increased by $57.96 million, reflecting the establishment of the new position.

Videos

31.10.2025

Positive

The Big 3: GOOGL, KOD, FTK

(KOD)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

(KOD)

KOD Stock Soars on Promising Phase III Data for Eye Disease Candidate

Kodiak Sciences Stock Is Surging Friday: What's Driving The Action?

Kodiak Sciences shares surge after eye drug succeeds in late-stage study

Kodiak Sciences Announces Positive Topline Results in GLOW2, the Second Phase 3 Study in Diabetic Retinopathy, Demonstrating Superiority of Zenkuda™ (tarcocimab tedromer) Over Sham

Investment Firm Doubles Down on Biotech Stock, Adds 386,000 Shares, According to Recent SEC Filing

Kodiak Sciences Stock Up 480% as One Fund Discloses $53 Million Buy

Inside a $58 Million Bet on Kodiak Amid $184 Million Offering and Phase 3 Readouts Ahead

Videos

KOD Stock Soars on Promising Phase III Data for Eye Disease Candidate

Kodiak Sciences Stock Is Surging Friday: What's Driving The Action?

Kodiak Sciences shares surge after eye drug succeeds in late-stage study

Kodiak Sciences Announces Positive Topline Results in GLOW2, the Second Phase 3 Study in Diabetic Retinopathy, Demonstrating Superiority of Zenkuda™ (tarcocimab tedromer) Over Sham

Investment Firm Doubles Down on Biotech Stock, Adds 386,000 Shares, According to Recent SEC Filing

Kodiak Sciences Stock Up 480% as One Fund Discloses $53 Million Buy

Inside a $58 Million Bet on Kodiak Amid $184 Million Offering and Phase 3 Readouts Ahead

Videos